ADMI
BMY icon

Albert D. Mason Inc’s Bristol-Myers Squibb BMY Stock Holding History

Albert D. Mason Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$438K Sell
7,218
-18
-0.2% -$1.05K 0.28% 91
2025
Q4 		$390K Buy
7,236
+213
+3% +$10.2K 0.26% 99
2025
Q3 		$317K Hold
7,023
– – 0.21% 106
2025
Q2 		$325K Buy
7,023
+60
+0.9% +$2.94K 0.24% 109
2025
Q1 		$425K Sell
6,963
-250
-3% -$14.6K 0.29% 102
2024
Q4 		$408K Buy
7,213
+41
+0.6% +$2.29K 0.27% 108
2024
Q3 		$371K Hold
7,172
– – 0.24% 115
2024
Q2 		$298K Sell
7,172
-35
-0.5% -$1.57K 0.2% 124
2024
Q1 		$391K Buy
7,207
+517
+8% +$26.3K 0.24% 120
2023
Q4 		$343K Hold
6,690
– – 0.23% 123
2023
Q3 		$388K Sell
6,690
-100
-1% -$6.13K 0.28% 120
2023
Q2 		$434K Sell
6,790
-985
-13% -$66K 0.3% 114
2023
Q1 		$539K Sell
7,775
-310
-4% -$21.9K 0.37% 103
2022
Q4 		$582K Hold
8,085
– – 0.42% 100
2022
Q3 		$575K Buy
8,085
+70
+0.9% +$5.08K 0.46% 88
2022
Q2 		$617K Hold
8,015
– – 0.46% 94
2022
Q1 		$585K Buy
8,015
+95
+1% +$6.38K 0.38% 113
2021
Q4 		$494K Buy
7,920
+2,580
+48% +$151K 0.29% 122
2021
Q3 		$316K Buy
5,340
+160
+3% +$10.5K 0.2% 139
2021
Q2 		$346K Buy
5,180
+265
+5% +$17.3K 0.21% 133
2021
Q1 		$310K Buy
4,915
+275
+6% +$17.1K 0.2% 130
2020
Q4 		$288K Buy
+4,640
New +$285K 0.2% 129

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Albert D. Mason Inc's BMY Position: Q1 2026 in Review

Albert D. Mason Inc reduced its Bristol-Myers Squibb (BMY) stake by 0.25% in Q1 2026, selling an estimated $1.05K and leaving 7,218 shares worth $438K. The position accounts for 0.28% of the portfolio, ranked #91.

Albert D. Mason Inc first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $617K in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Albert D. Mason Inc held 7,218 shares of Bristol-Myers Squibb worth $438K as of Q1 2026.
  • Albert D. Mason Inc sold 18 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.05K.
  • Bristol-Myers Squibb made up 0.28% of Albert D. Mason Inc's portfolio in Q1 2026, its #91 holding.
  • Albert D. Mason Inc first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • Albert D. Mason Inc's Bristol-Myers Squibb position peaked at $617K in Q2 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Albert D. Mason Inc's 13F filing for Q1 2026, filed 15 Apr 2026.